AGIO Next Earnings Date Notes

— Agios Pharmaceuticals (NASDAQ: AGIO) is a biopharmaceutical company focused on developing and delivering therapies for rare diseases caused by errors in cellular metabolism, with a particular emphasis on genetically defined diseases. The company’s lead asset is PYRUKYND® (mitapivat), which is approved for the treatment of adults with pyruvate kinase (PK) deficiency and is being studied for other hemolytic anemias such as thalassemia and sickle cell disease. For investors, it’s important to track key business metrics such as PYRUKYND’s commercial performance (including product sales and prescription growth), the status and results of ongoing clinical trials, the progression of pipeline candidates, and cash burn relative to cash on hand given the company’s heavy R&D investments. Listening to the earnings call, you should pay close attention to management’s commentary on market adoption for PYRUKYND, patient expansion opportunities, regulatory timelines, upcoming clinical milestones, and updates on partnerships or collaborative efforts. These factors will provide insight into Agios’s ability to sustain innovation, drive future revenue growth, and achieve long-term profitability. The next projected earnings date for AGIO is 10/29/2026 6:00 am (stay tuned for a confirmed earnings date once announced).

Agios Pharmaceuticals Next Earnings Date FAQ

On this page we presented the Agios Pharmaceuticals Next Earnings Date information for Agios Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, AGIO reported earnings of -1.690/share, with the earnings report taking place on 7/30/2026. For Q1 of 2026, AGIO reported earnings of -1.690/share, with the earnings report taking place on 4/29/2026. For Q4 of 2025, AGIO reported earnings of -1.860/share, with the earnings report taking place on 2/12/2026. For Q3 of 2025, AGIO reported earnings of -1.780/share, with the earnings report taking place on 10/30/2025. For Q2 of 2025, AGIO reported earnings of -1.930/share, with the earnings report taking place on 7/31/2025. Based on these past earnings dates, the projected next earnings date for AGIO is 10/29/2026 6:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Agios Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Agios Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Agios Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next AGIO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up AGIO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the AGIO next earnings date.